// App-Quantinova.ai

SAT0529 : Hydroxychloroquine Retinopathy: Update on Application of The 2011 Screening Guidelines in An Academic Practice

Researchers

Presenter

  • S.M.A. Shah

Principal Investigators

  • E.M. Schonbach

  • H.P. Scholl

  • M. Petri

Medical Centers

  • Medicine (Gastroenterology), Johns Hopkins University, Baltimore, Maryland, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetic retinopathy

Biomarkers

  • Interleukin 1 alpha

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved